Abbott to Spin Off Nutrition Business Into Independent Company
Abbott Laboratories said it will issue shares to existing investors for an independent company housing its Similac nutrition business.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
3 results loaded, newest first. End of these results.
Abbott Plans to Spin Off Nutrition Business Into Independent Company
Abbott plans to separate its nutrition business into an independent company with about $8.5 billion in annual sales.
Abbott Plans to Spin Off Nutrition Business by End of 2027
Abbott plans to separate its global Nutrition business, with approximately $8.5 billion in sales, into an independent public company through a share distribution to Abbott shareholders. The plan is subject to approvals.